{"org_id": "T000271167", "org_name_cn": "海南普利制药股份有限公司", "org_short_name_cn": "普利制药", "org_name_en": "Hainan Poly Pharm. Co.,Ltd", "org_short_name_en": "HNPOLY", "main_operation_business": "药物研发、注册、生产和销售。", "operating_scope": "　　兴办工厂，西药原料药、中间体和制剂、中成药、药用辅料的研发、生产、销售，卫生及医药信息服务。", "district_encode": "460108", "org_cn_introduction": "海南普利制药股份有限公司的主营业务为药物研发、注册、生产和销售；公司的主要产品为地氯雷他定分散片、地氯雷他定干混悬剂、地氯雷他定片、双氯芬酸钠肠溶缓释胶囊、克拉霉素缓释片、盐酸左氧氟沙星胶囊、注射用阿奇霉素、阿奇霉素干混悬剂、马来酸曲美布汀片。", "legal_representative": "范敏华", "general_manager": "范敏华", "secretary": "周茂", "established_date": 711043200000, "reg_asset": 437029856.0, "staff_num": 848, "telephone": "86-898-66661090", "postcode": "571127", "fax": "86-898-65710298", "email": "securities@hnpoly.com", "org_website": "www.hnpoly.com", "reg_address_cn": "海南省海口市美兰区桂林洋经济开发区", "reg_address_en": "", "office_address_cn": "海南省海口市美兰区桂林洋经济开发区", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1490630400000, "provincial_name": "海南省", "actual_controller": "范敏华 (33.89%)，朱小平 (7.10%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "范敏华", "executives_nums": 13, "actual_issue_vol": 30529405.0, "issue_price": 11.49, "actual_rc_net_amt": 314352863.0, "pe_after_issuing": 22.99, "online_success_rate_of_issue": 0.02623649, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}